Projects
Female athletes in high-impact sports are at increased risk of patellar tendinopathy, yet current screening methods poorly predict injury. We are developing a model combining ultrasound tendon biomarkers, training load, and indicators of low energy availability to identify athletes at risk to enable earlier intervention.
GLIDE is developing a personalised, non-invasive wearable that uses AI and EDA sensors to estimate glucose levels, aiming to reduce reliance on invasive CGM for people with diabetes.
The UK faces an opioid epidemic; this project integrates nalmefene implant into UK care pathways for high-risk transition groups (post-detox and prison release).
Phase 1 feasibility and signal-detection study evaluating the an acupressure REM Patch for supporting sleep recovery in NHS UK doctors following night-shift work.
MB1 is evaluating whether menstrual blood biomarkers can provide a less invasive way to identify chronic endometritis and reproductive tract microbiome changes by comparing menstrual blood with endometrial biopsy results.
Hypoxia challenge testing across experimentation pipeline from initial POC to ISO 80601‑2‑61 standard for smart ring company developing SpO2 measurement module
A double-blind, matched-pairs non randomised trial assessing the VictoryPatch in runners using VO2 Max and LTT as primary outcome measures
Development of a non-invasive MRI-based software-as-a-medical-device for fibrosis classification—without the need for additional MRI hardware or software upgrades.
A POC validating smart-phone SpO₂ measurement using "finger-on-camera" method to assess real-time hypoxia changes for validation to signal accuracy.
A multi-region dataset initiative providing labelled breast ultrasound, and MR images paired with biopsy results to support proprietary clinical or AI development applications.
